Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic and therapeutic implications of tumor-restrictive type III collagen in the breast cancer microenvironment.
Stewart DC, Brisson BK, Dekky B, Berger AC, Yen W, Mauldin EA, Loebel C, Gillette D, Assenmacher CA, Quincey C, Stefanovski D, Cristofanilli M, Cukierman E, Burdick JA, Borges VF, Volk SW. Stewart DC, et al. Among authors: assenmacher ca. NPJ Breast Cancer. 2024 Oct 2;10(1):86. doi: 10.1038/s41523-024-00690-y. NPJ Breast Cancer. 2024. PMID: 39358397 Free PMC article.
Tumor-restrictive type III collagen in the breast cancer microenvironment: prognostic and therapeutic implications.
Brisson BK, Dekky B, Berger AC, Mauldin EA, Loebel C, Yen W, Stewart DC, Gillette D, Assenmacher CA, Cukierman E, Burdick JA, Borges VF, Volk SW. Brisson BK, et al. Among authors: assenmacher ca. Res Sq [Preprint]. 2023 Apr 12:rs.3.rs-2631314. doi: 10.21203/rs.3.rs-2631314/v1. Res Sq. 2023. Update in: NPJ Breast Cancer. 2024 Oct 2;10(1):86. doi: 10.1038/s41523-024-00690-y. PMID: 37090621 Free PMC article. Updated. Preprint.
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer Cells.
McBrearty N, Cho C, Chen J, Zahedi F, Peck AR, Radaelli E, Assenmacher CA, Pavlak C, Devine A, Yu P, Lu Z, Zhang H, Li J, Pitarresi JR, Astsaturov I, Cukierman E, Rustgi AK, Stanger BZ, Rui H, Fuchs SY. McBrearty N, et al. Among authors: assenmacher ca. Mol Cancer Res. 2023 Mar 1;21(3):228-239. doi: 10.1158/1541-7786.MCR-22-0602. Mol Cancer Res. 2023. PMID: 36378658 Free PMC article.
Combination HSCT and intravenous AAV-mediated gene therapy in a canine model proves pivotal for translation of Krabbe disease therapy.
Bradbury AM, Bagel J, Swain G, Miyadera K, Pesayco JP, Assenmacher CA, Brisson B, Hendricks I, Wang XH, Herbst Z, Pyne N, Odonnell P, Shelton GD, Gelb M, Hackett N, Szabolcs P, Vite CH, Escolar M. Bradbury AM, et al. Among authors: assenmacher ca. Mol Ther. 2024 Jan 3;32(1):44-58. doi: 10.1016/j.ymthe.2023.11.014. Epub 2023 Nov 11. Mol Ther. 2024. PMID: 37952085
FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response.
Velalopoulou A, Karagounis IV, Cramer GM, Kim MM, Skoufos G, Goia D, Hagan S, Verginadis II, Shoniyozov K, Chiango J, Cerullo M, Varner K, Yao L, Qin L, Hatzigeorgiou AG, Minn AJ, Putt M, Lanza M, Assenmacher CA, Radaelli E, Huck J, Diffenderfer E, Dong L, Metz J, Koumenis C, Cengel KA, Maity A, Busch TM. Velalopoulou A, et al. Among authors: assenmacher ca. Cancer Res. 2021 Sep 15;81(18):4808-4821. doi: 10.1158/0008-5472.CAN-21-1500. Epub 2021 Jul 28. Cancer Res. 2021. PMID: 34321243 Free PMC article.
PARP11 inhibition inactivates tumor-infiltrating regulatory T cells and improves the efficacy of immunotherapies.
Basavaraja R, Zhang H, Holczbauer Á, Lu Z, Radaelli E, Assenmacher CA, George SS, Nallamala VC, Beiting DP, Meyer-Ficca ML, Meyer RG, Guo W, Fan Y, Modzelewski AJ, Spiegelman VS, Cohen MS, Fuchs SY. Basavaraja R, et al. Among authors: assenmacher ca. Cell Rep Med. 2024 Jul 16;5(7):101649. doi: 10.1016/j.xcrm.2024.101649. Cell Rep Med. 2024. PMID: 39019005 Free PMC article.
Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease.
Larouche-Lebel É, Loughran KA, Oyama MA, Solter PF, Laughlin DS, Sánchez MD, Assenmacher CA, Fox PR, Fries RC. Larouche-Lebel É, et al. Among authors: assenmacher ca. J Vet Intern Med. 2019 Jul;33(4):1571-1584. doi: 10.1111/jvim.15548. Epub 2019 Jun 28. J Vet Intern Med. 2019. PMID: 31254308 Free PMC article.
Increased tumor-infiltrating lymphocyte density is associated with favorable outcomes in a comparative study of canine histiocytic sarcoma.
Lenz JA, Assenmacher CA, Costa V, Louka K, Rau S, Keuler NS, Zhang PJ, Maki RG, Durham AC, Radaelli E, Atherton MJ. Lenz JA, et al. Among authors: assenmacher ca. Cancer Immunol Immunother. 2022 Apr;71(4):807-818. doi: 10.1007/s00262-021-03033-z. Epub 2021 Aug 20. Cancer Immunol Immunother. 2022. PMID: 34415404 Free PMC article.
49 results